Brendon Neuen

83PUBLICATIONS
220CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Biologically active moleculesPharmacogenomicsMajor global burdens of diseasePharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (83)

|Oct 16, 2026
High sensitivity C-reactive protein and the risk of cardio-kidney outcomes in adults with moderate to severe chronic kidney disease: a nationwide study.

|Oct 13, 2026
Validation of the Klinrisk CKD Progression Model in the Dapagliflozin and Prevention of Adverse Outcomes in CKD (DAPA-CKD) Population.

|Oct 08, 2026
The challenge of introducing aldosterone synthase inhibitors into multidisciplinary practice.

|Oct 01, 2026
Pharmacological treatment strategies to prevent heart failure across the cardiovascular-kidney-metabolic spectrum: an EJHF Expert Consensus Statement.

|Sep 05, 2026
Inflammation as a therapeutic target to improve kidney and cardiovascular outcomes.

|Sep 04, 2026
Efficacy and safety of canagliflozin are consistent across polypharmacy burden in CKD: the CREDENCE trial.

Pageof 14

Frequent Collaborators

35 joint publications

Hiddo Jl Heerspink

30 joint publications

Clare Arnott

18 joint publications

Bruce Neal

18 joint publications

Muthiah Vaduganathan